Compare IROQ & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IROQ | INCR |
|---|---|---|
| Founded | 1883 | 1994 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 84.4M | 78.0M |
| IPO Year | 2011 | N/A |
| Metric | IROQ | INCR |
|---|---|---|
| Price | $26.40 | $1.36 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.2K | ★ 14.4K |
| Earning Date | 10-31-2025 | 10-08-2025 |
| Dividend Yield | ★ 1.52% | N/A |
| EPS Growth | ★ 157.16 | N/A |
| EPS | ★ 1.60 | N/A |
| Revenue | $27,979,000.00 | ★ $72,158,312.00 |
| Revenue This Year | N/A | $69.54 |
| Revenue Next Year | N/A | $41.75 |
| P/E Ratio | $16.45 | ★ N/A |
| Revenue Growth | ★ 24.68 | N/A |
| 52 Week Low | $22.04 | $1.22 |
| 52 Week High | $26.50 | $1.79 |
| Indicator | IROQ | INCR |
|---|---|---|
| Relative Strength Index (RSI) | 65.18 | 48.70 |
| Support Level | $26.05 | $1.27 |
| Resistance Level | $26.14 | $1.38 |
| Average True Range (ATR) | 0.08 | 0.05 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 87.50 | 69.98 |
IF Bancorp Inc is a holding company mainly engaged in the business of directing, planning, and coordinating the business activities of Iroquois Federal. The company, in association, takes deposits from the general public and invests those deposits together with funds generated from operations and borrowings in various loans such as multi-family residential and mortgage loans, commercial real estate loans, home equity lines of credit, consumer loans, etc., and offers a variety of deposit accounts and alternative delivery channels. In addition to the traditional banking products and services, the group also offers a full line of property and casualty insurance products, annuities, mutual funds, individual securities, managed accounts, and other financial services.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.